Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
about
Access and hemostasis: femoral and popliteal approaches and closure devices-why, what, when, and how?Risks and complications of coronary angiography: a comprehensive reviewFemoral arterial closure using ProGlide® is more efficacious and cost-effective when ambulating early following cardiac catheterization.Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI RegistryThe effect of bivalirudin and closure device on bleeding outcomes after percutaneous coronary interventionsIdentification of hospital outliers in bleeding complications after percutaneous coronary intervention.Bleeding avoidance strategies. Consensus and controversyInfluence of Access, Anticoagulant, and Bleeding Definition on Outcomes of Primary Percutaneous Coronary Intervention: Early Experience of an US Academic CenterPrecision medicine to improve use of bleeding avoidance strategies and reduce bleeding in patients undergoing percutaneous coronary intervention: prospective cohort study before and after implementation of personalized bleeding risks.Comparison of percutaneous coronary intervention safety before and during the establishment of a transradial program at a teaching hospital.Access site complications after peripheral vascular interventions: incidence, predictors, and outcomes.Vascular closure device failure in contemporary practice.Initial experience with the AXERA 2 Femoral Access System in neurovascular proceduresIncidence of delayed angiographic femoral artery complications using the EXOSEAL vascular closure device.Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable AnalysisCritical lower limb ischemia from an embolized Angio-Seal closure deviceSimplified swift and safe vascular closure device deployment without a local arteriogram: Single center experience in 2074 consecutive patients.Design and rationale of the AngioSeal versus the Radial approach In acute coronary SyndromE (ARISE) trial: a randomized comparison of a vascular closure device versus the radial approach to prevent vascular access site complications in non-ST-segmenVascular closure devices in acute coronary syndromes: from arbitrary to a necessity?How serious a problem is bleeding in patients with acute coronary syndromes?Radial versus femoral access for percutaneous coronary intervention: implications for vascular complications and bleeding.Vascular access and closure in coronary angiography and percutaneous intervention.GuideLiner mother-and-child guide catheter extension: a simple adjunctive tool in PCI for balloon uncrossable chronic total occlusions.Minimizing femoral artery access complications during percutaneous coronary intervention: a comprehensive review.Achieving safe femoral arterial access.Safety and efficacy of percutaneous femoral artery access followed by Mynx closure in cerebral neurovascular procedures: a single center analysis.Complications with Angio-Seal™ vascular closure devices compared with manual compression after diagnostic cardiac catheterization and percutaneous coronary intervention.Direct thrombin inhibitors and vascular closure devices: same answers, same questions.Collagen plug vascular closure devices and reduced risk of bleeding with bivalirudin versus heparin plus abciximab in patients undergoing percutaneous coronary intervention for non st-segment elevation myocardial infarction.Bleeding complications in percutaneous coronary interventions.Closure for arterial access in balloon aortic valvuloplasty.Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial.Appropriate hemostasis by routine use of ultrasound echo-guided transfemoral access and vascular closure devices after lower extremity percutaneous revascularization.
P2860
Q26853717-916279EF-5E89-4877-90CE-463F053F1294Q27025085-F940F66E-F7D0-4B46-96E2-B96995CEC82BQ33753568-1C6EDA40-EBE5-47B0-95AE-382E82C426C3Q34272836-F1F2D897-8984-4E29-85F2-B379189943F0Q34304587-32CB3385-782E-4CBF-B993-773A0A1DCB91Q35002064-BA7CB81E-473E-4968-BAD5-4ED15737AE1CQ35079519-068C94F7-2938-43B0-8BCE-371807E6191BQ35141545-242D4F9F-548B-47AE-B590-5D09EB537B3FQ35714397-8F6C0A70-1040-4141-A653-9291482B194EQ35869476-D000082A-2481-4039-9D59-F6EDBF92584EQ35928767-5A43C396-0A01-495C-A816-A2AFDEB8FEA0Q36188849-3ECB7BB8-617C-4D82-929C-7890EA6209BAQ36589969-ADA9412A-F3B2-498C-8871-B18CE233E23DQ36589973-4D416E6B-7E8F-415D-ADE2-A2EF62F3070AQ36799394-91757645-A973-4490-B10B-8F3F7083051DQ37182512-882396E0-84A7-482A-B9C5-6F8D254FDCDAQ37188516-9B3834EF-58F9-4A80-A21C-6ED32850BC22Q37426083-FC11C9F4-789C-4208-A131-B55A10ABBF49Q37813166-ACA22024-6D14-493A-913C-9B2C85294EA2Q37888541-CCDD3A34-4C7E-470E-A483-F50ED5ADA421Q38021699-8FF97571-22CC-4922-AF42-E92CE801CE6FQ38062791-0CECD35A-85D6-4CA0-8F0B-1488E8367076Q38128616-54102A84-5A9B-4FCF-B0F4-E0D1C903FE97Q38200070-1F97502F-DCDF-4134-A4B9-3D5BE55F2A21Q38441624-89107979-CAE6-426B-809B-C610D0ACDB7EQ38453441-6EC82777-F47F-4249-AF52-80405E972110Q43691925-41029759-BB22-41FC-A1FB-19D579CE8A09Q44532960-0C009487-4953-4491-872B-65D2059C9DAEQ44901932-39A67963-34F5-43E3-AA35-F14D256F152FQ44947156-2562A202-DC89-4CA8-ADC6-D91CA8CDE673Q45998651-857A79C8-8318-4B94-A50C-6CE83CC9C0B6Q51058537-9D974EA0-6C32-4A2B-85A1-E4C895E545E6Q51243640-0329CEA1-5E42-4FDB-8F2A-929173E50F6A
P2860
Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Impact of femoral vascular clo ...... riage Strategy (ACUITY) trial.
@en
type
label
Impact of femoral vascular clo ...... riage Strategy (ACUITY) trial.
@en
prefLabel
Impact of femoral vascular clo ...... riage Strategy (ACUITY) trial.
@en
P2093
P1476
Impact of femoral vascular clo ...... riage Strategy (ACUITY) trial.
@en
P2093
Brent T McLaurin
David A Cox
Frederick Feit
Gregg W Stone
Martial Hamon
Ramin Ebrahimi
Steven V Manoukian
Timothy A Sanborn
P356
10.1161/CIRCINTERVENTIONS.109.896704
P577
2010-01-26T00:00:00Z